LOGIN  |  REGISTER
Recursion

Recent Insider Transactions - Conduit Pharmaceuticals (NASDAQ: CDT)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CDT Conduit Pharmaceuticals
Regan Andrew / director, 10 percent owner, officer: Chief Executive Officer
06/03/2025
Buy
$3.23
154,799
$500K
154,799